Adjuvant therapy for stage I and II non-small cell lung cancer

被引：1
作者：
Dorr, VJ
Perry, MC
机构：
[1] Div. of Hematology/Medical Oncology, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO 65203
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1997年 / 11卷 / 02期
关键词：
D O I：
10.1016/S0889-8588(05)70430-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Even after curative resection, the overall 5-year survival rate for stage I and II non-small cell lung cancer remains less than optimal. In an attempt to improve survival, adjuvant therapy after curative resection has been evaluated. Chemotherapy, immunotherapy, radiotherapy, and various combinations of these have been investigated as means to improve survival. This article reviews these studies. At this time, adjuvant therapy remains investigational and its use should be limited to clinical trials.
引用
收藏
页码：267 / +
页数：1
相关论文
共 50 条
[41]   Lobectomy versus proton therapy for stage I non-small cell lung cancer [J].
Sakane, Tadashi ;
Nakajima, Koichiro ;
Iwata, Hiromitsu ;
Nakano, Tomoharu ;
Hagui, Emi ;
Oguri, Masanosuke ;
Nomura, Kento ;
Hattori, Yukiko ;
Ogino, Hiroyuki ;
Haneda, Hiroshi .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 166 (06) :1490-+
[42]   Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: A phase II study [J].
Syrigos, Konstantinos N. ;
Konstantinou, Marios ;
Sepsas, Evangellos ;
Papamichales, George ;
Loullias, Achilleas ;
Belenis, Ionas ;
Skottis, Ionas ;
Charpidou, Andriani ;
Roussos, Charalambos .
ANTICANCER RESEARCH, 2007, 27 (4C) :2887-2892
[43]   Vaccines as adjuvant therapy for non-small cell lung cancer (NSCLC) [J].
Butts, Charles .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) :S220-S221
[44]   Is there a role for adjuvant therapy for resected non-small cell lung cancer? [J].
Jett, JR .
THORAX, 1999, 54 :S37-S41
[45]   Predictive markers in the adjuvant therapy of non-small cell lung cancer [J].
Filipits, Martin ;
Pirker, Robert .
LUNG CANCER, 2011, 74 (03) :355-363
[46]   Adjuvant therapy for locally advanced non-small cell lung cancer [J].
Keller, SM .
LUNG CANCER, 2003, 42 :S29-S34
[47]   ADJUVANT THERAPY IN OPERABLE NON-SMALL CELL LUNG-CANCER [J].
JOSS, R ;
BLEHER, EA ;
GOLDHIRSCH, A ;
KAUFMANN, M ;
BRUNNER, KW .
SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1983, 72 (16) :553-560
[48]   SURGICAL ADJUVANT THERAPY OF NON-SMALL CELL LUNG-CANCER [J].
HOLMES, EC .
CHEST, 1986, 89 (04) :S295-S300
[49]   Neoadjuvant vs Adjuvant Chemoimmunotherapy for Stage II-IIIB Non-Small Cell Lung Cancer [J].
Martins, Russell Seth ;
Razi, Syed Shahzad ;
Alnajar, Ahmed ;
Poulikidis, Kostantinos ;
Latif, M. Jawad ;
Luo, Jeffrey ;
Bhora, Faiz Y. .
ANNALS OF THORACIC SURGERY, 2024, 118 (03) :672-681
[50]   Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC) [J].
Lee, SW ;
Choi, EK ;
Chung, WK ;
Shin, KH ;
Ahn, SD ;
Kim, JH ;
Kim, SW ;
Suh, C ;
Lee, JS ;
Kim, WS ;
Kim, DS ;
Kim, DK ;
Park, SI ;
Sohn, KH .
LUNG CANCER, 2002, 37 (01) :65-71
12345